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Highlights  
 
• Many classes of antibiotic used for humans are also used in food animals, including 
the highest priority of the critically important antimicrobials for human medicine in 
the World Health Organisation’s list. 
• Penicillins and Tetracyclines classes were the most commonly used antibiotics in 
many countries. 
• Improve understanding of the use of antibiotics and factors influencing antibiotic use 
will help promoting prudent use of antimicrobials in livestock. 
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Patterns of antibiotic use in global pig production: a systematic review  
 
1. Abstract 
This review assesses the evidence for patterns of antibiotic use in pig on the basis of papers 
published in peer-reviewed journals in English between 2000 and 2017. Thirty-six articles were 
identified and reviewed, of which more than 85% of studies were conducted in Europe and North 
America. Penicillins and Tetracyclines groups were the most commonly used antibiotics in many 
countries. Oral medication in suckling and post-weaning periods were the most common applications 
of antibiotic administration in pig production. Antibiotic use is driven by age-specific diseases and the 
common pathogens causing these conditions where epidemiological profiles varied greatly across 
countries. In addition, the type and size of farm were associated with antibiotic use with finisher and 
larger farms using more antibiotics than farrow-to-finish and smaller farms. There is variation in the 
use of the highest priority critically important antimicrobials in humans across studies. However, this 
review indicates that they are still commonly used in pig production, for treatment and prevention of 
infection. This evidence calls for global efforts on the prudent use of antibiotics in response to the 
emergence of antimicrobial resistance (AMR) in the agricultural sector.  
 
Keywords: antibiotic; antimicrobial resistance; antibiotic use; pig; systematic review 
 
2. Introduction 
Antibiotics have been used routinely in farm animal production since the 1950s, in particular during 
intensive farming, in order to keep animals healthy and to increase productivity. The use of 
antibiotics in animals has raised concerns that the selective pressure on the bacteria population 
promotes antibiotic resistance. Despite the difficulties in demonstrating the transmission of resistant 
bacteria from animals to humans, many studies have shown evidence of human infection from 
resistant bacteria in animals (C. Liu et al., 2018; McCrackin et al., 2016; Nhung, Cuong, Thwaites, & 
Carrique-Mas, 2016). The discovery of a plasmid-mediated colistin resistant gene (MCR-1) in 
commensal Escherichia coli from pigs, pork products and humans in China, triggered global concern 
(Y.-Y. Liu et al., 2016). Colistin is considered a last resort antibiotic as it is one of the only antibiotics 
active in severe infections caused by hospital acquired multidrug-resistant (MDR) pathogens such as 
Pseudomonas aeruginosa, Acinetobacter baumannii and Enterobacteriaceae (Catry et al., 2015).  
 
Antibiotics in the same class usually have a similar mode of therapeutic action, with a range of 
effectiveness. Many classes of antibiotic used for humans are also used in food animals. The World 
Health Organisation (WHO) produces a list of all antimicrobials grouped into 3 categories based on 
their importance in treating human infections. (World Health Organization, 2017).  The classes of 
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drugs included in the list of critically important antimicrobials (CIA) for human medicine contain the 
last-resort antibiotics to treat severe infections caused by multidrug-resistant (MDR). The CIA list of 
Highest Priority Critically Important Antimicrobial includes Quinolones, 3rd and higher generation 
Cephalosporins, Macrolides and Ketolides, Glycopeptides and Polymixins class which includes colistin 
(World Health Organization, 2017). This WHO CIA list is referred to in the rest of this report.  
 
In animals, the use of antibiotics is common for not only treatment, but also for controlling the 
spread of infection (metaphylaxis), preventing infection (prophylaxis) particularly in periods of stress 
and vulnerability to infections, and improvement of feed efficiency and promotion of animal growth 
(Aarestrup, 2005). According to American Veterinary Medical Association,  the term “therapeutic” 
includes treatment, control, and prevention of disease (Association American Veterinary Medical, 
2019). The use of antibiotics as a growth promoter is considered non-therapeutic. Many countries 
including USA, Canada and Australia have implemented policies and regulations that medically 
important antimicrobials are prescription only medicines by licensed veterinarians (Australian 
Government Department of Health and Department of Agriculture and Water Resources, n.d.; 
Government of Canada, 2018; US Food and Drug Administration, 2011).  The use of antibiotics for 
growth promotion has been banned in the European Union since 2006 (Regulation (EC) No 
1831/2003 of the European Parliament and of the councel on additives for use in animal nutrition, 
2003). In contrast, other countries - including China and Brazil which are the large livestock producing 
and exporting countries- do not prohibit the use of antibiotics for growth promotion (Maron, Smith, 
& Nachman, 2013). 
 
Despite the concerns about the relationship between the use of antibiotics and AMR in food animals 
and AMR in humans, there are limited studies exploring the use of antibiotic in livestock and the 
factors that influence how farmers use them. To promote the prudent use of antibiotics in livestock, 
it is vital to have a better understanding of the current situation. This systematic review aims to 
analyse and synthesise the available published information on the pattern of antibiotic use in pigs.  
 
3. Method 
3.1. Scope of study and research question 
This study focuses on antibiotics. Before conducting the systematic review, the terms and 
explanations to be included were considered as follows. According to World Organisation for Animal 
Health (OIE) definition, an antimicrobial is considered as a naturally occurring, semi-synthetic or 
synthetic substance that exhibits antimicrobial activity (to kill or inhibit the growth of micro-
organisms) at concentrations attainable in vivo. Anti-helminthic and substances classed as 
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disinfectants or antiseptics are excluded from this definition (World Organisation for Animal Health, 
2011). In this study the word ‘pigs’ refers to all stages of swine production including breeding and 
gestation, farrowing, nursery and feeding and finishing. The word ‘pattern’ explains the use of 
antibiotics in terms of active ingredient; the route of administration such as injection or medicated 
feed; the purpose of the use including treatment, metaphylaxis, prophylaxis and growth promotion; 
and the frequency of the use by different farms and different stages of life cycle of pig production. 
The research questions in the review is: “What are the patterns of antibiotic use in terms of classes, 
routes of administration and purpose of the use and its associations with pig production?”. 
 
3.2. Identifying relevant literature 
The study applied the “SPIDER” tool, designed specifically to identify relevant quantitative studies 
(Cooke, Smith, & Booth, 2012). It covers the following: Sample: pig; Phenomenon of Interest: antibiotic 
use in pigs; Design: Observational studies; Evaluation: pattern of antibiotic use including active 
ingredient of antibiotic, route of administration, purpose of use including treatment, control, 
prevention and growth promotion; and Research: Quantitative research. 
 
Literature on the use of antibiotics in pigs was systematically reviewed between July to October 
2017. Relevant scientific papers published in English peer-reviewed journals were identified using the 
keyword combinations (antibiotic OR antimicrobial OR antibacterial) AND (livestock OR swine OR 
pig* OR farrow OR weaner OR finisher OR sow) AND (use OR utilisation OR consum* OR practice OR 
administration). 
 
The online electronic database through LSHTM databases: MEDLINE (http://ovidsp.tx.ovid.com; 1946 
until present), Scopus (http://www.scopus.com; 1823 until present) and Web of Science 
(http://apps.webofknowledge.com; 1970 until present) were searched with restriction of the date of 
publication between 2000 and 2017 to capture up-to-date data. To ensure a wide range of articles 
from different sources, additional searches were sourced through the reference lists of key articles.  
 
3.3. Eligibility assessment of studies and inclusion criteria 
Prior to a study being included within the review, the following criteria were considered: publication 
in English, and focus on antibiotic usage in pigs with high and moderate ranking of a quality 
assessment. 
 
Citations of all identified studies were downloaded into a reference management software (EndNote 
X8.0.2). In the first screening step, the duplicated studies were removed, through consideration of 
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the title and the abstract by comparison with the keywords. Full texts were further considered. 
Reviews, clinical research, pharmacokinetic, biopharmaceutical and experimental studies were 
excluded. In addition, studies focusing on antibiotic activity, specific diseases related to drug 
recommendations, associations of antibiotic use with antimicrobial resistance, relationship between 
interventions and antibiotic use, and effects of antibiotic treatment to AMR, animal productivity and 
animal management were excluded.  
 
Studies included in the qualitative synthesis were those that presented the pattern of antimicrobial 
use, and medium (50-75%) and high-ranking quality assessment (>75%). If a study explored data over 
many periods of time, then the updated data was selected for the review. 
 
3.4. Quality assessment  
The Critical Appraisal Skills Programme (CASP) was applied for quality assessment)(Critical Appraisal 
Skills Programme, n.d.). They were aggregated into a quality score based on four criteria: aim, 
method, result and application of the literature; Yes, No and Cannot tell are the assessment 
outcomes. With eleven questions, the score was categorised into three groups: weak means <50% 
having “yes” answers, moderate means 50-75% having “yes” answers, and high means >75% having 
“yes” answers (see Table A2 of annex). If the assessment by the reviewer was ‘no’ or ‘cannot tell’, the 
score for that question was zero; the score for yes was one. In this review, the studies were ranked 
by quality criteria. The quality ranking was classified into three groups: High meant >75% of all eleven 
sub-criteria were met, moderate meant 50-75% were met and weak meant <50% of criteria were 
met. 
 
3.5. Data extraction and synthesis 
Figure 1 shows the review process. All relevant articles in full texts were reviewed and summarised 
using a standardised data extraction table in an Excel spreadsheet.  
 
 
4. RESULTS 
4.1. Eligible studies 
Our search strategies identified a total of 2,588 articles (Appendix 1). After duplicates were removed 
and an initial review of titles and abstracts for relevance was conducted and 118 articles were found 
to be eligible for full-text screening on the basis of the inclusion criteria. Sixty-eight studies were 
found to be relevant and retained. Further screening excluded 31 papers; of which 16 papers were 
not related to pattern and factors influencing antibiotic use; two papers had inappropriate study 
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design; four papers focused on specific diseases using recommended antibiotics and relationship 
between interventions and antibiotic use; and ten papers were not related to pigs. Finally, 36 studies 
were included in this systematic review. Figure 1 showed the flow diagram of the process in 
screening papers. 
 
4.2. Study characteristics  
As shown in table 1, twenty-seven of studies (75%) were conducted between 2010 and 2017; the 
remaining 9 studies were conducted between 2000 and 2010 (25%). Most studies (72%) were 
conducted in Europe, with four studies in North America (11%), three in Asia (8%), and one each in 
Africa (3%) and Australia (3%). Diverse sources of data were used for the study such as farm surveys 
(39%), national databases (19%), farm-based survey and prescription data (14%), prescription data 
(8%), antibiotic application records (8%), veterinary survey (6%), pharmaceutical producer survey 
(3%) and farm-based survey and national data (3%). Among total studies reviewed, 9 studies (25%) 
were nationally representative. The result of the quality assessment of 36 studies showed that 21 
(58%) and 15 (42%) of studies are of high and medium quality respectively (see table 2A in Annex).  
 
4.3. Patterns of antibiotic use in pigs 
4.3.1 Patterns of antibiotic use 
4.3.1.1 Classes and active ingredients of antibiotic 
Some studies reported antibiotic use by active ingredient and others only by the class. In many 
studies the most common used antibiotic classes were the Penicillins and Tetracyclines.  
Benzylpenicillins consisted 61% of total use in a farm study in Sweden (Sjölund et al., 2016). 
Aminopenicillins were commonly reported accounting for 30-40% of total antibiotic use in studies 
from Sweden, Germany and Canada. (Glass-kaastra et al., 2013; Sjölund et al., 2016; Van Rennings et 
al., 2015). Twelve studies reported that Tetracyclines class  was the most commonly used including 
studies from Denmark, Japan, Netherlands, Australia, Spain and France (Bondt, Jensen, Puister-
Jansen, & van Geijlswijk, 2013; Bos et al., 2013; Casal, Mateu, Mejía, & Martín, 2007; Chauvin, 
Beloeil, Orand, Sanders, & Madec, 2002; Dupont, Diness, Fertner, Kristensen, & Stege, 2017; Hosoi, 
Asai, Koike, Tsuyuki, & Sugiura, 2014; Jordan et al., 2009; Vieira, Pires, Houe, & Emborg, 2011), and 
was as high as 54.4% in a study from Germany (Merle et al., 2013). Within the Tetracyclines class, 
doxycycline was used 62.3% of total use in the study in Austria (Moreno, 2012). The share of 
chlortetracycline use was 23.9% in a farm study in Vietnam (Van Cuong et al., 2016), and formed the 
majority of antibiotics use in all pig stages in the United States (Apley, Bush, Morrison, Singer, & 
Snelson, 2012).  In the farm study in Switzerland, the most common antibiotic class was the 
reductase inhibitors and combinations class” of drugs, specifically sulfadimidine, sulfathiazole and 
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trimethoprim, accounting for 62.1%. (Arnold, Gassner, Giger, & Zwahlen, 2004) while Bacitracin was 
the most reported of antibiotic use (24.8%) in the farm study in Vietnam (Van Cuong et al., 2016). 
Fattening farms in the study from Austria applied Lincosamides in 71.9% of antibiotic use (Trauffler, 
Griesbacher, Fuchs, & Köfer, 2014). 
 
The use of highest priority Critically Important Antimicrobials in humans was also reported differently 
across countries. The studies from France and Austria reported the use of Macrolides at 20% and at 
7.4% of total use (Chauvin et al., 2002) (Trauffler, Obritzhauser, Raith, Fuchs, & Köfer, 2014). Based 
on the electronic drug application records from 75 pig farms in Austria, Fluoroquinolones were 
reported at 2.4% of total use, third and fourth generation Cephalosporins were 2.2% of total use 
(Trauffler, Obritzhauser, et al., 2014), while the use of Fluoroquinolones at 5 % and third generation 
Cephalosporins at 11% were reported from 47 pig farms in the study in Belgium (Sjölund et al., 2016). 
The study in 60 French pig herds received colistin in 30% of total antibiotic use (Sjölund et al., 2016), 
12.2% in the study in Vietnam using the internet-based survey of commercial feed producer (Van 
Cuong et al., 2016), 33% and 61% in  the survey in 45 farrow-to-finish farms and 67 fattening farms in 
Spain (Moreno, 2012) and 34.4% in fattening farms in 75 pig farms in Austria (Trauffler, Griesbacher, 
et al., 2014).  
 
4.3.1.2 Routes of administration  
Generally, oral medication was the most common route of antibiotic administration in pig 
production. Several studies reported more than 90% of antibiotic substances were administered 
orally via both feed and water (Merle et al., 2012; Van Rennings et al., 2015; Rajić et al., 2006; 
Chauvin et al., 2002). About 70-90% of the oral use was reported in many countries, for example 87% 
in the study from France (Sjölund et al., 2016), 86% in the study from Austria (Trauffler, Griesbacher, 
et al., 2014), 73% in the study from Denmark (Dupont et al., 2017), 71% in the study from Germany 
(Sjölund et al., 2016) and 70% in the study from Belgium (Sjölund et al., 2016). In the UK farm study, 
60-75% of the farmers had used medicated feeds for their weaners (Stevens et al., 2007). Another 
study indicated that oral use of antibiotics was higher than parenteral indication (97.43% VS 2.46%) 
(Merle et al., 2013).This is in contrast to another study that farmers applied very low levels of oral 
antibiotics, 13% of all routes (Sjölund et al., 2016). 
 
A wide range of active ingredients was commonly used for oral medication, including: colistin 
(Filippitzi, Callens, Pardon, Persoons, & Dewulf, 2014; Moreno, 2012; Timmerman et al., 2006), 
amoxicillin(Filippitzi et al., 2014; Timmerman et al., 2006), sulfonamides (Bondt et al., 2013; 
Timmerman et al., 2006), oxycycline (Bondt et al., 2013), doxycycline (Moreno, 2012; Timmerman et 
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al., 2006), chlortetracycline, lincomycin,tiamulin, tylosin, and penicillin G (in water) (Rosengren et al., 
2008). However, ceftiofur (Filippitzi et al., 2014; Timmerman et al., 2006), enrofloxacin (Moreno, 
2012), amoxycillin (Moreno, 2012; Timmerman et al., 2006), penicillin (Moreno, 2012; Rosengren et 
al., 2008) and tulztromycin (Filippitzi et al., 2014) were commonly used for parenteral medication.  
 
The oral administration of antibiotics (either through feed or water) was commonly used for group 
treatment, while injection was the commonly applied for treatment of individual sick animals 
(Sjölund, Backhans, Greko, Emanuelson, & Lindberg, 2015; Trauffler, Griesbacher, et al., 2014). A 
study showed that 90% of group treatment was administered between birth and ten weeks of age; 
while only 20% of group treatment was administered during the fattening period (Callens et al., 
2012). Group treatments were primarily administered via oral medication in weaners and via 
parenteral route for individual sucking piglets (Filippitzi et al., 2014), particularly after castration or 
when diarrhoea occurred (Timmerman et al., 2006). In one study reported ninety-four percent of 
group treatment at farm for a respiratory infection (prior to a definitive diagnosis) was carried out 
with tetracycline, beta-lactams and sulphonamides while 90% of group treatment at farm for enteric 
disease used colistin (Casal et al., 2007). 
 
4.3.1.3 Indications: treatment, metaphylaxis, prophylaxis and growth promotion  
Few studies in this review reported the indication for antibiotics use. A vast majority, 93% of total 
antibiotics administered were for prophylaxis, whereas metaphylaxis or treatments were much 
smaller at 7% of total antibiotics in Belgium (Callens et al., 2012; Filippitzi et al., 2014). Main therapy 
indications in farrow-to-finish and fattening farms were metaphylactic/prophylactic measures 
(Trauffler, Griesbacher, et al., 2014). Chlrotetracycline and carbadox were the most commonly used 
antibiotics for growth promotion, prevention and treatment of infectious diseases and tiamulin was 
commonly used for prevention and treatment of infectious diseases (Apley et al., 2012). 
 
Only few studies reported the use of antibiotic by distinguishing between metaphylaxis and 
prophylaxis (Callens et al., 2012; Filippitzi et al., 2014), which ‘prophylactic use’ means treatment of 
healthy pigs to prevent disease from occurring and ‘metaphylactic use’ means treatment of clinically 
healthy pigs in the same group where some animals had showed clinical symptoms of disease. Based 
on American Veterinary Medical Association, both ‘prophylaxis’ and ‘metaphylaxis’ means 
therapeutic (Association American Veterinary Medical, 2019) and commonly described as 
“preventative use” as a general term. However, both terms are not applied in certain situations such 
as the use of antibiotics within a group of animals without definite diagnosis. 
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4.3.2 Association between the use of antibiotics and pig production 
4.3.2.1 Phase of pig production 
Six studies examined the association of antibiotic use and the phase of pig production. Antibiotics 
were commonly used during suckling and post-weaning periods. One study reported more than 80% 
of antibiotics were applied to pigs at less than ten weeks of age (Callens et al., 2012). Four studies 
reported that weaners received the most antibiotics (Chauvin et al., 2002; Fertner et al., 2015; 
Jensen, Emborg, & Aarestrup, 2012; Sjölund et al., 2016). However, another study showed that 
treatment of suckling piglets was more common than weaners (Sjölund et al., 2016), and similar 
findings were reported in two studies (Merle et al., 2013; Van Rennings et al., 2015).  
 
Based on the cross-sectional study conducted among 227 farrow-to-finish pig herds in four European 
countries, there was a significant association between antibiotic use across different age categories. 
The lowest use of antibiotics among fatteners reported in France and Sweden, while the least use in 
breeders reported in Belgium and Germany (Sjölund et al., 2016). Similarly, the studies from 
Denmark and France reported the least application of antibiotics in sows, with about 26% and 17% of 
total use in all phases respectively (Chauvin et al., 2002; Jensen et al., 2012). Another study using 
veterinary prescription data reported almost zero use of antibiotic among the finishers in Denmark 
(Fertner et al., 2015). However, one study from Belgium reported that the use of antibiotics was 
higher in the farrowing period than fattening period (Callens et al., 2012). Another study showed that 
eight veterinarians in Saskatchewan and Alberta applied more than 90% of the antibiotics for 
treatment of disease in sows, compared to less than 20% in other phases (Rosengren et al., 2008). 
However, the farm study in Vietnam reported  there was no significant difference in antibiotics use 
for prevention across three age groups (piglets, fatteners and sows) (Kim et al., 2013). 
 
The class and active ingredient of antibiotic also varies by different phases of pig production (Table 
2). Aminopenicillin, tetracyclines, trimethoprim-sulfonamides, tylosin and colistin were commonly 
used in all studies (5 studies each). Chlortetracycline (4 and 3 studies), oxytetracycline (3 and 4 
studies), tylosin (5 studies) and lincosamide (4 studies) were commonly used in weaners and 
finishers. Colistin in Polymyxin class was used in weaners in five studies, while aminoglycosides were 
mostly used in finishers (4 studies).  
 
 
One study reported the route of administration in relation to the phase of production. Weaners and 
finishers were more likely to receive oral antibiotics while sows and piglets received parenteral 
administration (Jensen et al., 2012). 
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There are variations in the indication for antibiotic use by phases of pig production. For example, 
more than half of pig farms (58%) used oral antibiotics as a routine prophylaxis for fatteners (Casal et 
al., 2007);  medicated feeds are used mostly as growth promoters for weaners (Stevens et al., 2007); 
and there was less use of antibiotic as a growth promoter and therapeutic use in sows than in piglets; 
but it was equally used for piglets and fattening pigs (Kim et al., 2013). 
 
4.3.2.2 Diseases in pigs  
Five studies reported the use of antibiotics by type of diseases in different geographical areas. A farm 
study in Denmark, showed herds received more frequent use of antibiotics for gastrointestinal 
infections (74-83% of total indication in weaners and 56-65% in finishers), 9-24% for respiratory 
indication, and 15-30% for treatment of locomotor and central nervous systems conditions, skin and 
urinary tract infections (Jensen et al., 2012). The farm study in Canada showed that 27% of antibiotic 
treatment reported by ten veterinarians was for multiple systems infection (Glass-kaastra et al., 
2013). Base on 303 French pig veterinarians survey, 10% of antibiotics are used for treatment of 
diseases and conditions such as cough, porcine proliferative enteropathy and post-weaning 
Escherichia coli (Chauvin et al., 2002). 
 
In all age-groups, the most commonly-used antibiotic classes for the treatment of gastrointestinal 
infections were tetracyclines, lincosamides, Pleuromutilins (Jensen et al., 2012) and Macrolides 
(Jensen et al., 2012; Trauffler, Griesbacher, et al., 2014), while the most common use for the 
treatment of respiratory infections were chlortetracycline, tetracycline and amoxicillin (Van Rennings 
et al., 2015). Considering the phase of pig, the most commonly used was colistin in piglets and 
weaners, and tylosin in fatteners for gastrointestinal conditions (Van Rennings et al., 2015). 
Pleuromutilins were commonly used for respiratory tract infections in sow and piglets (Jensen et al., 
2012). Use of antibiotics for gastrointestinal infection in breeding farms was also common (Trauffler, 
Griesbacher, et al., 2014).   
 
4.3.2.3 Farm characteristic and management 
Six studies reported a relationship between antibiotic use and type of farm. Overall, finisher farms 
were more likely to use antibiotics than farrow-to-finish farms (84-94% versus 43%-92% respectively) 
(Merle et al., 2012), (90% versus 54.3% respectively) (Moreno, 2012). (van der Fels-Klerx, Puister-
Jansen, van Asselt, & Burgers, 2011). Sow farms used fewer antibiotics than farrow-to-finish farms 
(van der Fels-Klerx et al., 2011). Moreover, finisher farms had the highest use (14.91%) of the highest 
priority and critically important antimicrobials, while it was 7.83% in breeding farms and 12.54% in 
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farrow-to-finish farms (Trauffler, Obritzhauser, et al., 2014). In finishing farms, fattening units were 
more likely to use a routine antimicrobial prophylaxis than farrow-to-finish farms (OR=11.7, 95CI: 
4.1− 33.3) and use antibiotics for growth promotion (OR= 2.8, 11.7, 95CI:1.2− 6.9) (Casal et al., 2007); 
about a half (46%) and one third (30%) of antibiotics were applied for metaphylatic and prophylactic 
purposes in farrow-to-finish and fattening farms (Trauffler, Griesbacher, et al., 2014).  
 
Pig density had a positive association with the use of antibiotics (Bos et al., 2013; Stevens et al., 
2007). The number of sows presented on the farm has a positive correlation with the amount of 
antibiotic use (van der Fels-Klerx et al., 2011). Different findings in few studies showed that small 
herd size had significantly higher antibiotic use than moderate and large herd size (Vieira et al., 
2011); and the number of pigs in farms had no association with the use of antibiotics (Casal et al., 
2007) and the use of growth promoters (Stevens et al., 2007). One study reported that industrial 
production system had higher antibiotic use than a semi-industrial production system and small farm 
holders (Kim et al., 2013).  
 
There was only one study that documented the association between vaccination and antibiotic use. 
The vaccination of suckling piglets and weaners was significantly associated with the greater use of 
in-feed antibiotics (Stevens et al., 2007). In terms of farm management, one study found that weaner 
production in indoor pig farming systems had higher use of antibiotics in medicated feed (64-74%) 
than the outdoor farming (60%); it is noted that UK is the only country that raise commercial sow 
outdoor(Stevens et al., 2007). One study showed that improved farm sanitation and management 
contributes to a reduction in antibiotic consumption without productivity losses (Fertner et al., 
2015); however, another study reported that the use of antibiotics had no association with farm 
management (Casal et al., 2007).  
 
4.3.2.4 Other factors  
Other factors also contribute to the use of antibiotics. The volume of tetracycline used in the spring 
was five-fold higher than other seasons (Van Rennings et al., 2015). In the study from the UK, there 
was a large variations of in-feed antibiotics in weaners and growers, and in individual weaners in 
different pork quality assurance schemes (Stevens et al., 2007). In term of farm location, farms 
located in high pig-density areas have a positive correlation with the amount of antibiotic use (van 
der Fels-Klerx et al., 2011). 
 
Only one study examined the educational status of farmers, and there was a significant association 
between low education and poor knowledge on antibiotic use (Eltayb, Barakat, Marrone, Shaddad, & 
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Sta, 2012).  Farmers perceived that use of antibiotic contributes to their profitability from raising pigs 
(Stevens et al., 2007). 
 
5. Discussion 
Understanding the current pattern of antibiotic use in livestock is important in order  to support 
optimal antibiotic use, which may potentially slow down the emergence of AMR in animal 
production. Studies on antibiotic use have increased considerably over the last decade, and in this 
review, the majority of studies were conducted between 2010 and 2017. Most of the studies were 
conducted in Europe, particularly in high-income countries (HICs) where there are higher research 
capacities and data availability. Due to the population size, demand for animal-source food is higher 
among low- and middle-income countries (LMICs) than in HICs (Robinson & Pozzi, 2011).  More 
evidence on consumption of antibiotics in LMICs is required for proper and timely responses to AMR 
such as optimizing consumptions and uses of antibiotics.  
 
Pattern of antibiotic use 
Common classes of antibiotics used varied across countries. Overall, Penicillins and Tetracyclines 
class were the most commonly used antibiotic in pigs. These findings were similar to another review 
which reported Penicillins, Tetracyclines and Macrolides were the most common use in pig 
production (Cuong, Padungtod, Thwaites, & Carrique-Mas, 2018). This was probably because they 
are relatively cheap and cost-effective compared to other antibiotics  (“OIE LIST OF ANTIMICROBIALS 
OF VETERINARY IMPORTANCE Criteria used for categorisation List of antimicrobials,” n.d.). Penicillins 
have bactericidal actions against Gram-negative and Gram-positive pathogens (Lobanovska & Pilla, 
2017). They were commonly used for prophylaxis and treatment of septicaemia, respiratory and 
urinary tract infections in a broad range of animal species. Tetracyclines were widely used for the 
treatment of respiratory diseases caused by Actinobacillus pleuropneumonia and Pasteurella 
multocida; however, resistance to tetracyclines is common. For example, 22% of Pasteurella 
multocida, 15% of Actinobacillus pleuropneumoniae and 82% of Streptococcus suis were reported to 
be resistant to tetracyclines (de Jong et al., 2014).  
 
This review confirms that antibiotics of veterinary importance defined in the highest priority critically 
important antimicrobials in human in WHO’s list (World Health Organization, 2017), were still 
commonly used in swine production.  
 
The use of antibiotics without definitive diagnosis and proper indications has raised global concern, 
especially with the emergence of AMR in the agricultural sector. The first attempt to withdraw non-
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therapeutic antibiotics was in the UK in 1969 when the Swann Joint Committee suggested restricting 
the use of medicated feed at a sub-therapeutic level in livestock (Swann, Baxter, & Field, 1969). 
Many countries have banned antibiotic use for growth promotion. However, this review shows that 
the use of antibiotics for infection prevention is still globally common in pig production, in order to 
prevent production loss in particular in intensive industrial farming. The standard prophylactic 
protocol for the whole herd can be more convenient to administer and less labour-intensive to 
manage than treatment of individual sick animals.  
 
Antibiotics choice and route of administration associated with specific diseases and age groups  
Choices of antibiotics were driven by age-specific diseases and the common pathogens for these 
conditions. Gastrointestinal and respiratory tract infections are common in pigs at all stages and are 
easily transmitted within and between herds. However, some specific diseases are more common in 
weaners such as septicaemia caused by Actinobacillus suis and Mycoplasma infection than others. In 
finishers, diarrhoea, porcine haemorrhagic enteropathy (Lawsonia intracellulalis) and swine 
dysentery (Bachyspira hyodysentary) are common pathogens causing gastrointestinal infection, 
whereas enzootic pneumonia (Mycoplama hyopnuemoniae), mycoplasma induced respiratory 
disease (Pasturella multocida), pleuropnuemonia (Actinobacillus pleuropnueumoniae) are common 
pathogens causing respiratory infection (Burch, 2013). Type of bacteria in animal are drivers for type 
of antibiotic use (Jordan et al., 2009).  
 
Colistin was most commonly used for gastrointestinal conditions in piglets and weaners, tylosin in 
fatteners and sows (Van Rennings et al., 2015). Farmers used Pleuromutilins for respiratory tract 
infections in sow and piglets (Jensen et al., 2012) and beta-lactam antibiotics in piglets, weaners and 
fattening pigs (Van Rennings et al., 2015). However, the choice of antibiotics depends on market 
availability and cost in different countries. For example, while the most common respiratory 
pathogens in Danish swine production, Actinobacillus pleuropneumoniae, Pasturella multocida, and 
Streptococcus suis infections are fully susceptible to penicillin (Aarestrup, Oliver Duran, & Burch, 
2008), penicillin only constitutes a minor share of the prescriptions for respiratory disease, whereas 
Tetracyclines and Pleuromutilins are widely used. Possibly they have relatively lower costs; 
aminopenicillins are more expensive and parenteral use of benzylpenicillins is less convenient in 
administration (Jensen et al., 2012). 
 
Choices of antibiotic are also guided by route of administration. Oral application is a major route in 
weaners and fatteners, whereas parenteral is applied more in sows than piglets and fatteners, such 
as through the use of benzylpenicillin (Merle et al., 2014).  In finishers, however, parenteral 
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benzylpenicillins are applied to individual treatment of sick pigs, although other drugs such as tylosin 
and lincomycin are mainly administered through feed (Rajić et al., 2006; Rosengren et al., 2008).  
 
The use of antibiotic associated with farm management 
Farm management can be associated with antibiotic use, such as the type of farm, size of farm and 
vaccination status. This review shows that finisher farms used higher volumes of antibiotics than 
farrow-to-finish farms (24,30), in particular for metaphylactic and prophylactic measures, and growth 
promotion(Casal et al., 2007; Trauffler, Griesbacher, et al., 2014).  
 
Large farms were more likely to use medicated feeds compared to smaller-sized farms (Bos et al., 
2013; Kim et al., 2013; Stevens et al., 2007; van der Fels-Klerx et al., 2011). One possible explanation 
of the high use of antibiotics is that larger-sized farms have a greater risk of transmission of 
pathogens within herds than smaller farms, although this review is inconclusive as contradictory 
findings were reported (Vieira et al., 2011). However, there are multiple factors which influence the 
use of antibiotics, such as farm biosecurity practices, density, level of stress in the herd, vaccination 
status, quality of feed, farmer knowledge and disease prevalence rates. Good farm biosecurity such 
as all-in all-out production and a single supplier of weaners has been identified as common practice 
in herds which lead to a reduction in disease transmissions and lower antibiotic use (Fertner et al., 
2015) . Vaccination has been recommended as an alternative strategy to prevent disease 
contributing to  optimizing antibiotic usage (Postma et al., 2015). It has shown beneficial return of 
investment despite the costs for vaccines (Alarcon, Rushton, Nathues, & Wieland, 2013). However, 
the higher use of in-feed antibiotics was significantly associated with the vaccination of pigs in some 
age groups including suckling piglets, weaners and sows (Stevens et al., 2007). This finding can be 
confounded by other factors such as poor bio-security and farm management, low health status of 
the herd and high disease prevalence.   
 
The use of antibiotic associated with other factors 
The use of antibiotics was highly dependent on the farm management and person in charge of the 
daily routines. The initiation of treatment depended on the ability of early detection of diseased 
animals and the level of farmers’ perceptions and responses to the clinical signs in animals (Fertner 
et al., 2015). Farmers were likely to have a limited understanding of antibiotics, particularly those in 
low- and middle-income countries. One study in Cambodia indicated that none of the farmers 
demonstrated an understanding about the action and indication for antibiotics (Om & Mclaws, n.d.). 
A study in Sudan found a significant association between farmers’ low education level and poor 
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knowledge on antibiotic use and AMR awareness (Eltayb et al., 2012). All these challenges can lead to 
inappropriate use of antibiotics. 
 
Veterinarians play important roles in animal health and antibiotic stewardship; and often farmers 
rely on veterinarian’s advice on pig health, choices and use of antibiotics (Visschers et al., 2015). 
Despite their critical role, veterinarians’ prescription decisions are based on “expert opinion” or 
views from “opinion leaders” or from internet sources, rather than scientific and peer-reviewed data 
(Vandeweerd et al., 2012) or laboratory resistant profiles. Representatives from pharmaceutical 
companies, when serving as advisors to farmers on disease management, may have conflict of 
interests to offer their products. In Belgium, on average, 43% of the income among pig veterinarians 
came from selling pharmaceutical products (Maes et al., n.d.) for which prudent use of antibiotics 
can be at risk due to potential conflict of interests.  
 
The prevalence of pathogens in pigs and levels of resistance and susceptibility to different antibiotics 
is an important evidence to guide antibiotic selection and support prudent use. Despite critical 
contributions, nearly half of all veterinarians in a study in 25 European countries (44.3%) seldom 
collect a sample for bacterial identification and drug sensitivity tests in laboratory (De Briyne, 
Atkinson, Pokludová, Borriello, & Price, 2013). In addition, law and enforcement and availability of 
antibiotics influences the use of antibiotics. Sweden and Denmark’s law restricts the use of 
fluoroquinolones and third and fourth generation Cephalosporins in pigs (Guidelines for the prudent 
use of antimicrobials in veterinary medicine. Practical examples., 2015).  
 
Limitations of the review  
There are a number of limitations which need to be considered in interpreting the findings from this 
review. This review covers 36 studies published in English; where studies in non-English speaking 
countries may offer different or similar findings.  More than 85% of the studies reviewed were 
conducted of in Europe and North America, limiting the relevance of the findings to LMIC. Diversity in 
study design is a major challenge for an in-depth comparative analysis and synthesis; a few studies 
could be considered nationally representative, while others were small scale studies. These 
challenges require careful interpretation. Different data collection methods including face-to-face 
interviews with farmers, internet-based surveys, and mail surveys to pig farmers or veterinarians 
may affect the validity of the findings. Use of antibiotics based on survey questionnaires cannot 
detect the misuse and off-label use, where other approaches are needed such as prescription 
reviews.  As noted in our recent review there is also huge variability in how studies have measured 
the quantity of antibiotic use making it very difficult to make any comparisons.  Some studies 
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measure the use of antibiotics as a percentage of total use, while other studies calculated in specific 
units such as animal daily dose. Some studies reported the use by class of antibiotic, while other 
studies reported active ingredient of antibiotic (Lekagul, Tangcharoensathien, & Yeung, 2018). The 
EU is developing a standard unit for antibiotic measurement, called defined daily dose for animal 
(DDDvets) of active ingredient which take into account differences in dosing, pharmaceutical forms 
and routes of administration used (European Medicines Agency, 2015). 
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Figure 1 Flow diagram of the screening process of the literature  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records excluded (2,470) due to the following reasons:  
- Duplication removed [497] 
- Screen title and abstract by comparison with 
keywords [1,973] 
Full text retrieved for screening (118) 
Records excluded (50) on the basis of  
- No reference to any key aspect of pattern of 
antimicrobial use and associations of factors 
influencing the use of antimicrobials [19]  
- No full text in English [2] 
- Inappropriate study design: review, clinical research, 
pharmacokinetic, etc. [7] 
- Focus on specific disease related to drug 
recommendation, associations of antimicrobial use 
with antimicrobial resistance, relationship between 
interventions and antibiotic use [21] 
- Non-specific to pigs [1] 
Full-text articles assessed for eligibility (68) 
Records excluded (31) on the basis of 
- No reference to any key aspect of pattern of 
antimicrobial use and associations of factors 
influencing the use of antimicrobials [16] 
- Inappropriate study design [2] 
- Focus on specific disease related to drug 
recommendation and relationship between 
interventions and antibiotic use [4] 
- Non-specific to pigs [10] 
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Potential relevant studies identified through database and source searching (2,588) 
- Electronic database searching (MEDLINE [703], Scopus [808], Web of Science [1,070]) 
- Additional searching from citations [7] 
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Table 1 Characteristics of the reviewed studies 
Characteristics N=36 
2010-2017 27 (75%) 
2000-2010 9 (25%) 
Geographic area  
Europe a 27 (75%) 
North America b 4 (11%) 
Asia c 3 (8%) 
Africa d 1 (3%) 
Australia e 1 (3%) 
Data source of antibiotics  
Farm based survey 14 (39%) 
National database 
(consumption/sale/prescription) 
7 (19%) 
Farm based survey and prescription data 5 (14%) 
Prescription data 3 (8%) 
Antibiotic application records 3 (8%) 
Veterinarian survey 2(6%) 
Pharmaceutical producer survey  1 (3%) 
Farm based survey and national data 1 (3%) 
Quality assessment by authors   
High (>75%) 21 (58%) 
Moderate (50-74%) 15 (42%) 
a Europe: Denmark (n=7), Germany (n=6), Belgium (n=5), France (n=3), Netherlands (n=3), Sweden 
(n=3), Switzerland (n=3), Austria (n=2), Spain (n=2), UK (n=1) 
b North America: Canada (n=3), USA (n=1) 
c Asia: Vietnam (n=2), Japan (n=1) 
d Africa: Sudan (n=1) 
e Australia: Australia (n=1) 
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Table 2 Number of studies reporting data sources of active by geographical areas 
 Europe 
(27) 
North America 
(4) 
Asia 
(3) 
Africa 
(1) 
Australia (1) 
Farm based survey (14) 11 
(Callens et al., 2012; 
Casal, Mateu, Mejía, 
& Martín, 2007; 
Dupont, Diness, 
Fertner, Kristensen, 
& Stege, 2017; 
Jensen, Jorsal, & 
Toft, 2017; Moreno, 
2012; Sjölund et al., 
2016; Sjölund, 
Backhans, Greko, 
Emanuelson, & 
Lindberg, 2015; 
Stevens et al., 2007; 
Timmerman et al., 
2006; Visschers et 
al., 2014, 2015) 
1 
(Rajić, Reid-
Smith, 
Deckert, 
Dewey, & 
McEwen, 
2006) 
1 
(Kim et al., 
2013) 
1 
(Eltayb, 
Barakat, 
Marrone, 
Shaddad, & 
Sta, 2012) 
- 
National database 
(consumption/sale/pres
cription) (7) 
5 
(Aarestrup, Vibeke, 
Jacobsen, & 
Wegener, 2010; 
Bondt, Jensen, 
Puister-Jansen, & 
van Geijlswijk, 2013; 
Bos et al., 2013; 
Jensen, Emborg, & 
Aarestrup, 2012; 
Vieira, Pires, Houe, & 
Emborg, 2011) 
(Bondt et al., 2013; 
Bos et al., 2013; de 
Jong et al., 2014; 
Jensen et al., 2012) 
1 
(Apley, Bush, 
Morrison, 
Singer, & 
Snelson, 2012) 
1 
(Hosoi, Asai, 
Koike, 
Tsuyuki, & 
Sugiura, 
2014) 
- - 
Farm based survey and 
prescription data (5) 
4 
(Merle et al., 2012, 
2013, 2014; Van 
Rennings et al., 
2015) 
- - - 1 
(Jordan et 
al., 2009) 
Prescription data (3) 2 
(Arnold, Gassner, 
Giger, & Zwahlen, 
2004; Fertner et al., 
2015) 
1 
(Glass-kaastra 
et al., 2013) 
- - - 
Antibiotic application 
records (3) 
3 
(Trauffler, 
Griesbacher, Fuchs, 
& Köfer, 2014; 
Trauffler, 
- - - - 
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Obritzhauser, Raith, 
Fuchs, & Köfer, 2014; 
van der Fels-Klerx, 
Puister-Jansen, van 
Asselt, & Burgers, 
2011) 
Veterinarian survey (2) 1 
(Chauvin, Beloeil, 
Orand, Sanders, & 
Madec, 2002) 
1 
(Rosengren et 
al., 2008) 
- - - 
Pharmaceutical 
producer survey (1) 
- - 1 
(Van Cuong 
et al., 2016) 
- - 
Farm based survey and 
national data (1) 
1 
(Filippitzi, Callens, 
Pardon, Persoons, & 
Dewulf, 2014) 
- - - - 
 
 
 
 
 
 
 
 
 
Table 3: Number of studies reporting use of antibiotic class and active ingredient, by phase of pig 
production  
Antibiotic class 
and active 
ingredient 
 
Total 
studies (N) 
Phase of pig production 
Breeders Sucking piglet Weaner Fattener/ 
finisher 
Penicillins 2  
(Jensen et 
al., 2012; 
Rajić et al., 
2006) 
2  
(Jensen et al., 
2012; Rajić et 
al., 2006) 
 - 2  
(Jensen et al., 
2012; Rajić et 
al., 2006) 
2  
(Jensen et al., 
2012; Rajić et 
al., 2006) 
- benzylpenicillins 2  
(Sjölund et 
al., 2016, 
2015) 
1  
(Sjölund et al., 
2016) 
2  
(Sjölund et al., 
2016, 2015) 
1  
(Sjölund et al., 
2016) 
1  
(Sjölund et al., 
2016) 
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- aminopenicillin 5  
(Dupont et 
al., 2017; 
Jensen et 
al., 2012; 
Sjölund et 
al., 2016, 
2015; Van 
Rennings et 
al., 2015) 
5  
(Dupont et al., 
2017; Jensen et 
al., 2012; 
Sjölund et al., 
2016, 2015; Van 
Rennings et al., 
2015) 
4 
(Dupont et al., 
2017; Sjölund 
et al., 2016, 
2015; Van 
Rennings et 
al., 2015) 
5  
(Jensen et al., 
2012, 2017, 
Sjölund et al., 
2016, 2015; Van 
Rennings et al., 
2015) 
4  
(Jensen et al., 
2012; Sjölund et 
al., 2016, 2015; 
Van Rennings et 
al., 2015) 
-procaine 
penicillin 
(&dihydrostrepto
mycin) 
2 
(Dupont et 
al., 2017; 
Sjölund et 
al., 2015) 
2  
(Dupont et al., 
2017; Sjölund et 
al., 2015) 
2  
(Dupont et al., 
2017; Sjölund 
et al., 2015) 
1  
(Sjölund et al., 
2015) 
2  
(Dupont et al., 
2017; Sjölund et 
al., 2015) 
- amoxicillin-
clavalunic acid 
1  
(Jensen et 
al., 2017) 
 -  - 1  
(Jensen et al., 
2017) 
-  
Tetracyclines 5  
(Jensen et 
al., 2017, 
2012; 
Sjölund et 
al., 2016; 
Van 
Rennings et 
al., 2015; 
Merle et 
al., 2012) 
4  
(Jensen et al., 
2012; Merle et 
al., 2012; 
Sjölund et al., 
2016; Van 
Rennings et al., 
2015) 
3  
(Merle et al., 
2014; Sjölund 
et al., 2016; 
Van Rennings 
et al., 2015) 
4  
(Jensen et al., 
2012, 2017; 
Sjölund et al., 
2016; Van 
Rennings et al., 
2015) 
4 
(Jensen et al., 
2012; Merle et 
al., 2014; 
Sjölund et al., 
2016; Van 
Rennings et al., 
2015) 
- doxycycline 2 
(Dupont et 
al., 2017; 
Sjölund et 
al., 2015) 
-  - 1  
(Dupont et al., 
2017) 
2 
(Dupont et al., 
2017; Sjölund et 
al., 2015) 
- chlortetracycline 4 
(Apley et 
al., 2012; 
Dupont et 
al., 2017; 
Rajić et al., 
2006; Van 
Rennings et 
al., 2015) 
2 
(Rajić et al., 
2006; Van 
Rennings et al., 
2015) 
1 
(Van Rennings 
et al., 2015) 
4 
(Apley et al., 
2012; Dupont et 
al., 2017; Rajić 
et al., 2006; Van 
Rennings et al., 
2015) 
3 
(Apley et al., 
2012; Rajić et 
al., 2006; Van 
Rennings et al., 
2015) 
- oxytetracycline 3 
(Apley et 
al., 2012; 
Rajić et al., 
2006; 
Sjölund et 
al., 2015) 
2 
(Rajić et al., 
2006; Sjölund et 
al., 2015) 
1  
(Sjölund et al., 
2015) 
3 
(Apley et al., 
2012; Rajić et 
al., 2006; 
Sjölund et al., 
2015) 
3 
(Apley et al., 
2012; Rajić et 
al., 2006; 
Sjölund et al., 
2015) 
Sulphonamides  1 
(Merle et 
al., 2014) 
1 
(Merle et al., 
2014) 
1 
(Merle et al., 
2014) 
  1 
(Merle et al., 
2014) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 28 
-trimethoprim-
sulphonamides  
5 
(Dupont et 
al., 2017; 
Jensen et 
al., 2017, 
2012; 
Sjölund et 
al., 2016, 
2015) 
4 
(Dupont et al., 
2017; Jensen et 
al., 2012; 
Sjölund et al., 
2016, 2015) 
3  
(Dupont et al., 
2017; Sjölund 
et al., 2016, 
2015) 
4  
(Jensen et al., 
2012, 2017, 
Sjölund et al., 
2016, 2015) 
3 
(Jensen et al., 
2012; Sjölund et 
al., 2016, 2015) 
-sulfadiazine 1 
(Van 
Rennings et 
al., 2015) 
1 
(Van Rennings 
et al., 2015) 
1 
(Van Rennings 
et al., 2015) 
1 
(Van Rennings 
et al., 2015) 
1 
(Van Rennings 
et al., 2015) 
Macrolides 4 
(Jensen et 
al., 2012; 
Merle et 
al., 2014; 
Sjölund et 
al., 2016, 
2015) 
4 
(Jensen et al., 
2012; Merle et 
al., 2014; 
Sjölund et al., 
2016, 2015) 
3 
(Merle et al., 
2014; Sjölund 
et al., 2016, 
2015) 
3 
(Jensen et al., 
2012; Sjölund et 
al., 2016, 2015) 
4 
(Jensen et al., 
2012; Merle et 
al., 2014; 
Sjölund et al., 
2016, 2015) 
-tylosin 5 
(Apley et 
al., 2012; 
Dupont et 
al., 2017; 
Rajić et al., 
2006; 
Sjölund et 
al., 2015; 
Van 
Rennings et 
al., 2015) 
2 
(Rajić et al., 
2006; Van 
Rennings et al., 
2015) 
1  
(Van Rennings 
et al., 2015) 
5 
(Apley et al., 
2012; Dupont et 
al., 2017; Rajić 
et al., 2006; 
Sjölund et al., 
2015; Van 
Rennings et al., 
2015) 
5 
(Apley et al., 
2012; Dupont et 
al., 2017; Rajić 
et al., 2006; 
Sjölund et al., 
2015; Van 
Rennings et al., 
2015) 
-tilmicosin 2 
(Apley et 
al., 2012; 
Rajić et al., 
2006) 
-  -  1 
(Apley et al., 
2012) 
2 
(Apley et al., 
2012; Rajić et 
al., 2006) 
Pleuromutilins 2 
(Merle et 
al., 2014; 
Sjölund et 
al., 2016) 
2 
(Merle et al., 
2014; Sjölund et 
al., 2016) 
2 
(Merle et al., 
2014; Sjölund 
et al., 2016) 
1  
(Sjölund et al., 
2016) 
2 
(Merle et al., 
2014; Sjölund et 
al., 2016) 
-tiamulin 4 
(Apley et 
al., 2012; 
Dupont et 
al., 2017; 
Rajić et al., 
2006; 
Sjölund et 
al., 2015) 
1  
(Dupont et al., 
2017) 
1  
(Dupont et al., 
2017) 
3 
(Apley et al., 
2012; Dupont et 
al., 2017; 
Sjölund et al., 
2015)  
4 
(Apley et al., 
2012; Dupont et 
al., 2017; Rajić 
et al., 2006; 
Sjölund et al., 
2015) 
Lincosamides          
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- lincosamides 4 
(Apley et 
al., 2012; 
Merle et 
al., 2014; 
Rajić et al., 
2006; 
Sjölund et 
al., 2016) 
1 
(Merle et al., 
2014; Rajić et 
al., 2006; 
Sjölund et al., 
2016) 
2 
(Merle et al., 
2014; Sjölund 
et al., 2016) 
4 
(Apley et al., 
2012; Jensen et 
al., 2017; Rajić 
et al., 2006; 
Sjölund et al., 
2016) 
4 
(Apley et al., 
2012; Merle et 
al., 2014; Rajić 
et al., 2006; 
Sjölund et al., 
2016) 
- lincosamides 
and 
spectinomycin 
3 
(Jensen et 
al., 2012; 
Rajić et al., 
2006; 
Sjölund et 
al., 2016) 
3 
(Jensen et al., 
2012; Rajić et 
al., 2006; 
Sjölund et al., 
2016) 
1  
(Sjölund et al., 
2016) 
3 
(Jensen et al., 
2012; Rajić et 
al., 2006; 
Sjölund et al., 
2016) 
3 
(Jensen et al., 
2012; Rajić et 
al., 2006; 
Sjölund et al., 
2016) 
Polymyxin      
colistin 5 
(Jensen et 
al., 2012, 
2017, 
Sjölund et 
al., 2016, 
2015; Van 
Rennings et 
al., 2015) 
3  
(Jensen et al., 
2012; Sjölund et 
al., 2016; Van 
Rennings et al., 
2015) 
3 
(Sjölund et al., 
2016, 2015; 
Van Rennings 
et al., 2015) 
5 
(Jensen et al., 
2012, 2017, 
Sjölund et al., 
2016, 2015; Van 
Rennings et al., 
2015) 
3 
(Jensen et al., 
2012; Sjölund et 
al., 2016; Van 
Rennings et al., 
2015) 
Aminoglycosides 4 
(Jensen et 
al., 2012; 
Merle et 
al., 2014; 
Sjölund et 
al., 2016) 
3  
(Jensen et al., 
2012; Merle et 
al., 2014; 
Sjölund et al., 
2016) 
2 
(Merle et al., 
2014; Sjölund 
et al., 2016) 
3 
(Jensen et al., 
2012, 2017; 
Sjölund et al., 
2016) 
4 
(Jensen et al., 
2012; Merle et 
al., 2014; 
Sjölund et al., 
2016) 
Amphenicols 2 
(Jensen et 
al., 2012; 
Sjölund et 
al., 2016) 
2 
(Jensen et al., 
2012; Sjölund et 
al., 2016) 
1  
(Sjölund et al., 
2016) 
2 
(Jensen et al., 
2012; Sjölund et 
al., 2016) 
2 
(Jensen et al., 
2012; Sjölund et 
al., 2016) 
Cephalosporins 2 
(Jensen et 
al., 2012; 
Merle et 
al., 2014) 
2 
(Jensen et al., 
2012; Merle et 
al., 2014) 
1 
(Merle et al., 
2014) 
1 
(Jensen et al., 
2012) 
2 
(Jensen et al., 
2012; Merle et 
al., 2014) 
-3rd & 4th 
generation 
cephalosporins  
1  
(Sjölund et 
al., 2016) 
1  
(Sjölund et al., 
2016) 
1  
(Sjölund et al., 
2016) 
1  
(Sjölund et al., 
2016) 
1  
(Sjölund et al., 
2016) 
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Fluoroquinolones 3 
(Jensen et 
al., 2012; 
Merle et 
al., 2014; 
Sjölund et 
al., 2016) 
3 
(Jensen et al., 
2012; Merle et 
al., 2014; 
Sjölund et al., 
2016) 
2                   
(Merle et al., 
2014; Sjölund 
et al., 2016) 
2 
(Jensen et al., 
2012; Sjölund et 
al., 2016) 
3 
(Jensen et al., 
2012; Merle et 
al., 2014; 
Sjölund et al., 
2016) 
- enrofloxacin 1  
(Sjölund et 
al., 2015) 
1  
(Sjölund et al., 
2015) 
1  
(Sjölund et al., 
2015) 
1  
(Sjölund et al., 
2015) 
1  
(Sjölund et al., 
2015) 
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APPENDIXES 
Appendix 1 
I.  Search Strategy 
Structured Database Search (Search terms and results) 
o MEDLINE: N= 703 articles 
- (Antibiotic.mp. or exp Anti-Bacterial Agents) (704,921)  
- (Antimicrobial agents.mp. or Anti-Infective Agents) (61,091) 
- (livestock or swine or pig* or farrow or weaner or sow).mp. [mp=title, abstract, original 
title, name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier, synonyms] (519,570) 
- (Use* or usage or consume or consumption or practiceor or administration or oral or 
feed or injection).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier, synonyms] (6,635,975) 
o Scopus: N= 808 articles 
( TITLE-ABS-KEY ( antibiotic  OR  antimicrobial  OR  antibacterial )  AND  TITLE-ABS-KEY ( 
livestock  OR  swine  OR  pig*  OR  farrow  OR  weaner  OR  finisher  OR  sow )  AND  TITLE-
ABS-KEY ( use  OR  utilisation  OR  consum*  OR  practice  OR  administration ) )  AND  ( 
LIMIT-TO ( PUBYEAR ,  2017 )  OR  LIMIT-TO ( PUBYEAR ,  2016 )  OR  LIMIT-TO ( PUBYEAR ,  
2015 )  OR  LIMIT-TO ( PUBYEAR ,  2014 )  OR  LIMIT-TO ( PUBYEAR ,  2013 )  OR  LIMIT-TO ( 
PUBYEAR ,  2012 )  OR  LIMIT-TO ( PUBYEAR ,  2011 )  OR  LIMIT-TO ( PUBYEAR ,  2010 )  OR  
LIMIT-TO ( PUBYEAR ,  2009 )  OR  LIMIT-TO ( PUBYEAR ,  2008 )  OR  LIMIT-TO ( PUBYEAR ,  
2007 )  OR  LIMIT-TO ( PUBYEAR ,  2006 )  OR  LIMIT-TO ( PUBYEAR ,  2005 )  OR  LIMIT-TO ( 
PUBYEAR ,  2004 )  OR  LIMIT-TO ( PUBYEAR ,  2003 )  OR  LIMIT-TO ( PUBYEAR ,  2002 )  OR  
LIMIT-TO ( PUBYEAR ,  2001 )  OR  LIMIT-TO ( PUBYEAR ,  2000 ) )  AND  ( LIMIT-TO ( 
DOCTYPE ,  "ar" )  OR  LIMIT-TO ( DOCTYPE ,  "sh" ) )  AND  ( LIMIT-TO ( SUBJAREA ,  "AGRI" 
)  OR  LIMIT-TO ( SUBJAREA ,  "VETE" ) )  AND  ( LIMIT-TO ( LANGUAGE ,  "English" ) )  AND  
( LIMIT-TO ( SRCTYPE ,  "j" ) )   
o Web of Science: N= 1,070 articles 
TOPIC: (antibiotic or antimicrobial or antibacterial) AND TOPIC: (livestock or swine or pig 
or farrow or weaner or finisher or sow) AND TOPIC: (use or utilisation or consum* or 
practice or administration) 
Refined by: PUBLICATION YEARS: (2016 OR 2006 OR 2015 OR 2005 OR 2014 OR 2004 OR 
2012 OR 2002 OR 2013 OR 2003 OR 2017 OR 2000 OR 2011 OR 2001 OR 2009 OR 2010 OR 
2007 OR 2008) AND WEB OF SCIENCE CATEGORIES: (VETERINARY SCIENCES) AND 
DOCUMENT TYPES: ( ARTICLE ) 
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, ESCI Timespan=1970-2018 
Table A1 Search terminology to be used in literature review. 
  Search term 
I antimicrobial (Free text) OR antimicrobial (MeSH term) OR antibacterial (Free text) OR 
antibacterial (MeSH term) OR antibiotic (Free text) OR antibiotic (MeSH term) 
II livestock (Free text) OR swine (Free text) OR pig* (Free text) OR farrow (Free text) OR 
weaner (Free text) OR finisher (Free text) OR sow (Free text) 
III use (Free text) OR utilisation (Free text) OR consum* (Free text) OR practice (Free text) 
OR administration (Free text)  
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Table A2 Quality assessment of included studies 
Author, year Q1  Method  Result  Application  Rank* 
  Q2 Q3 Q4 Q5 Q6  Q7 Q8 Q9  Q10 Q11   
2017                 
Dupont, et al. (Dupont, Diness, 
Fertner, Kristensen, & Stege, 2017) 
Y  Y Y Y Y Y  Y Y Y  Y Y  H 
Jensen, et al. (Jensen, Jorsal, & 
Toft, 2017) 
Y  Y Y Y Y Y  Y Y Y  Y Y  H 
2016                 
Cuong, et al. (Van Cuong et al., 
2016) 
Y  Y N N Y Y  Y Y Y  Y Y  H 
Sjölund, et al. (Sjölund et al., 2016) Y  Y N N Y Y  Y Y Y  Y Y  H 
2015                 
Fertner et al (Fertner et al., 2015) Y  CT N N Y N  Y Y Y  Y Y  M 
Van Rennings, et al. (Van Rennings 
et al., 2015) 
Y  Y Y N Y Y  Y Y Y  Y Y  H 
Visschers, et al. (Visschers et al., 
2015) 
Y  Y N N Y Y  Y Y Y  Y Y  H 
Sjölund, et al. (Sjölund, Backhans, 
Greko, Emanuelson, & Lindberg, 
2015) 
Y  Y Y N Y Y  Y Y Y  Y Y  H 
2014                 
Filippitzi et al. (Filippitzi, Callens, 
Pardon, Persoons, & Dewulf, 2014) 
Y  Y CT N CT CT  Y Y Y  Y Y  M 
Hosoi, et al. (Hosoi, Asai, Koike, 
Tsuyuki, & Sugiura, 2014) 
Y  Y CT N N N  Y N Y  Y Y  M 
Merle, et al. (Merle et al., 2014) Y  Y N N Y N  Y Y Y  Y Y  M 
Trauffler et al. (Trauffler, 
Obritzhauser, Raith, Fuchs, & 
Köfer, 2014) 
Y  Y N N Y N  Y Y Y  Y Y  M 
Trauffler et al. (Trauffler, 
Griesbacher, Fuchs, & Köfer, 2014) 
Y  Y N N Y N  Y Y Y  Y Y  M 
Visschers, et al (Visschers et al., 
2014) 
Y  Y CT Y Y Y  Y Y Y  Y Y  H 
2013                 
Bondt, et al. (Bondt, Jensen, 
Puister-Jansen, & van Geijlswijk, 
2013) 
Y  Y Y CT CT Y  Y Y Y  Y Y  H 
Bos, et al. (Bos et al., 2013) Y  Y Y Y Y Y  Y Y Y  Y Y  H 
Glass-Kaastra, et al. (Glass-kaastra 
et al., 2013) 
Y  Y N N Y CT  Y Y Y  Y Y  M 
Kim, et al. (Kim et al., 2013) Y  Y N N Y CT  Y Y Y  Y Y  M 
Merle, et al. (Merle et al., 2013) Y  Y N N Y N  Y Y Y  Y Y  M 
2012                 
Apley, et al. (Apley, Bush, 
Morrison, Singer, & Snelson, 2012) 
Y  Y Y N Y Y  Y N Y  Y Y  H 
Callens, et al. (Callens et al., 2012) Y  Y Y N Y Y  Y Y Y  Y Y  H 
Eltayb, et al (Eltayb, Barakat, 
Marrone, Shaddad, & Sta, 2012) 
Y  Y CT N Y CT  Y N Y  Y Y  M 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 33 
Merle, et al. (Merle et al., 2012) Y  Y N N Y N  Y Y Y  Y Y  M 
Moreno, et al (Moreno, 2012) Y  Y Y N Y Y  Y Y Y  Y Y  H 
2011                 
Jensen, et al (Jensen, Emborg, & 
Aarestrup, 2012) 
Y  Y N N Y Y  Y Y Y  Y Y  H 
van der Fels-Klerx, et al. (van der 
Fels-Klerx, Puister-Jansen, van 
Asselt, & Burgers, 2011) 
Y  Y Y N Y Y  N Y N  Y Y  M 
Vieira, et al. (Vieira, Pires, Houe, & 
Emborg, 2011) 
Y  Y Y Y Y Y  Y Y Y  Y Y  H 
Aarestrup, et al. (Aarestrup, 
Vibeke, Jacobsen, & Wegener, 
2010) 
Y  Y Y Y Y Y  Y Y Y  Y Y  H 
2009                 
Jordan, et al. (Jordan et al., 2009) Y  Y Y Y Y Y  Y Y Y  Y Y  H 
2008                 
Rosengren, et al (Rosengren et al., 
2008) 
Y  CT N N Y N  Y Y Y  Y Y  M 
2007                 
Casal, et al (Casal, Mateu, Mejía, & 
Martín, 2007) 
Y  Y N N Y Y  Y Y Y  Y Y  M 
Stevens, et al (Stevens et al., 2007) Y  Y N N Y N  Y Y Y  Y Y  M 
2006                 
Rajic, et al. (Rajić, Reid-Smith, 
Deckert, Dewey, & McEwen, 2006) 
Y  Y N N Y Y  Y Y Y  Y Y  M 
Timmerman, et al. (Timmerman et 
al., 2006) 
Y  Y Y Y Y Y  Y Y Y  Y Y  H 
2004                 
Arnold, et al. (Arnold, Gassner, 
Giger, & Zwahlen, 2004) 
Y  Y Y N Y Y  Y Y Y  Y Y  H 
2002                 
Chauvin, et al (Chauvin, Beloeil, 
Orand, Sanders, & Madec, 2002) 
Y  Y Y N Y Y  Y Y Y  Y Y  H 
*score >75 = high (H), 50-74 = medium (M) and <50 = low (L) *score >75 = high (H), 50-74 = medium 
(M) and <50 = low (L) 
Note: 
Q1 = Did the study address a clearly focused issue? 
Q2 = Did the authors use an appropriate method to answer their question? 
Q3 = Were the subjects recruited in an acceptable way? 
Q4 = Were the measures accurately measured to reduce bias? 
Q5 = Were the data collected in a way that addressed the research issue? 
Q6 = Did the study have enough participants to minimize the play of chance? 
Q7 = How are the results presented and what is the main result? 
Q8 = Was the data analysis sufficiently rigorous? 
Q9 = Is there a clear statement of findings? 
Q10 = Can the results be applied to the local population? 
Q11 = How valuable is the research? 
Y = Yes (clearly described) 
N = No (Not described) 
CT = Cannot tell (described but with limited detail 
 
